Abstract:Background: Activated phosphoinositide 3 kinase (PI3K) -delta syndrome (APDS) is an inborn error of immunity with variable clinical phenotype of immunodeficiency and immune dysregulation and caused by gain-of-function mutations in PIK3CD. The hallmark of immune phenotype is increased proportions of transitional B cells and plasmablasts (PB), progressive B cell loss, and elevated levels of serum IgM. Objective: To explore unique B cell subsets and the pathomechanisms driving B cell dysregulation beyond the transitional B cell stage in APDS. Methods: Clinical and immunological data was collected from 24 patients with APDS. In five cases, we performed an in-depth analysis of B cell phenotypes and cultured purified naive B cells to evaluate their survival, activation, Ig gene class switch recombination (CSR), PB differentiation and antibody secretion. We also analyzed PB differentiation capacity of sorted CD27(-)IgD(-) double-negative B (DNB) cells. Results: The patients had increased B cell sizes and higher proportions of IgM(+) DNB cells than healthy controls (HC). Their naive B cells exhibited increased death, impaired CSR but relatively normal PB differentiation. Upon stimulation, patient's DNB cells secreted a similar level of IgG but a higher level of IgM than DNB cells from HC. Targeted therapy of PI3K inhibition partially restored B cell phenotypes. Conclusions: The present study suggests additional mechanistic insight into B cell pathology of APDS: (1) decreased peripheral B cell numbers may be due to the increased death of naive B cells; (2) larger B cell sizes and expanded DNB population suggest enhanced activation and differentiation of naive B cells into DNB cells; (3) the impaired CSR yet normal PB differentiation can predominantly generate IgM-secreting cells, resulting in elevated IgM levels.

Mutual Inhibition Between Prkd2 and Bcl6 Controls T Follicular Helper Cell Differentiation

Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model.

Thymic Selection Can Compensate for Mutations Affecting T Cell Activation and Generate a Normal T Cell Repertoire in Mutant Mice

BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population

Follicular Regulatory T Cells Repress Cytokine Production by Follicular Helper T Cells and Optimize IgG Responses in Mice

A Bcl6 Intronic Element Regulates T Follicular Helper Cell Differentiation

B cell-intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice

BCL6 Controls Contact-Dependent Help Delivery During Follicular T-B Cell Interactions

CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy

IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation

Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1

The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers.

The BTB-kelch Protein KLHL6 is Involved in B-Lymphocyte Antigen Receptor Signaling and Germinal Center Formation

Cooperative Transcriptional Repression by BCL6 and BACH2 in Germinal Center B-cell Differentiation.

Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses

Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner

Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the <i>PIK3CD</i> Gene

TGFβ prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation

The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment

Bcl6 is the nexus transcription factor of T follicular helper cell (TFH) differentiation via a set of repressor-of-repressor gene circuits